CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)
J Kranendonk, L H Willems, Rj van der Vijver-Coppen, M Coenen, E Adang, R Donders, C J Zeebregts, V Deneer, Mmpj Reijnen, C Kramers, M C Warlé
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)'. Together they form a unique fingerprint.